Changing the Paradigm: Elimination - Not Only of Cervical Cancer

Overview

Journal Gynecol Oncol Rep

Publisher Elsevier

Date 2024 Jul 24

PMID 39045263

Authors

Jacob Bornstein

Koray Gorkem Sacinti

Mario Preti

Salem Billan

Hosna Razeghian

Colleen K Stockdale

Affiliations

Soon will be listed here.

Abstract

The WHO's initiative to eliminate cervical cancer by 2030 does not address the increasing incidence of vulvar, anal, and oropharyngeal cancers linked to high-risk HPV. Currently, the prevention of these three cancers faces various obstacles, such as a lack of specialized screening programs, well-defined management guidelines, and widespread public awareness. Without any interventions, the incidence of these three cancers will likely rise in the upcoming years, increasingly affecting younger individuals. We recommend expanding the WHO's initiative to include vulvar, anal, and oropharyngeal cancers. This involves developing screening and management protocols similar to those for cervical cancer, implementing gender-neutral HPV vaccination programs, establishing clear referral pathways to specialized centers, promoting public awareness, and providing education to healthcare providers and high-risk individuals.

References

Kalliala I, Athanasiou A, Veroniki A, Salanti G, Efthimiou O, Raftis N . Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature. Ann Oncol. 2020; 31(2):213-227. PMC: 7479506. DOI: 10.1016/j.annonc.2019.11.004. View

Clifford G, Georges D, Shiels M, Engels E, Albuquerque A, Poynten I . A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Int J Cancer. 2020; 148(1):38-47. PMC: 7689909. DOI: 10.1002/ijc.33185. View

Preti M, Joura E, Vieira-Baptista P, van Beurden M, Bevilacqua F, Bleeker M . The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus.... J Low Genit Tract Dis. 2022; 26(3):229-244. PMC: 9232287. DOI: 10.1097/LGT.0000000000000683. View

Gillison M, DSouza G, Westra W, Sugar E, Xiao W, Begum S . Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100(6):407-20. DOI: 10.1093/jnci/djn025. View

Falcaro M, Castanon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J . The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021; 398(10316):2084-2092. DOI: 10.1016/S0140-6736(21)02178-4. View

Yakin M, Seo B, Hussaini H, Rich A, Hunter K . Human papillomavirus and oral and oropharyngeal carcinoma: the essentials. Aust Dent J. 2018; 64(1):11-18. DOI: 10.1111/adj.12652. View

Stier E, Clarke M, Deshmukh A, Wentzensen N, Liu Y, Poynten I . International Anal Neoplasia Society's consensus guidelines for anal cancer screening. Int J Cancer. 2024; 154(10):1694-1702. DOI: 10.1002/ijc.34850. View

Hohn A, Brambs C, Hiller G, May D, Schmoeckel E, Horn L . 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd. 2021; 81(10):1145-1153. PMC: 8494521. DOI: 10.1055/a-1545-4279. View

Villa A, Patton L, Giuliano A, Estrich C, Pahlke S, OBrien K . Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews. J Am Dent Assoc. 2020; 151(4):245-254.e24. DOI: 10.1016/j.adaj.2019.10.010. View

10.

Faber M, Sand F, Albieri V, Norrild B, Kjaer S, Verdoodt F . Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer. 2017; 141(6):1161-1169. DOI: 10.1002/ijc.30821. View

11.

de Sanjose S, Alemany L, Ordi J, Tous S, Alejo M, Bigby S . Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013; 49(16):3450-61. DOI: 10.1016/j.ejca.2013.06.033. View

12.

Albuquerque A, Stockdale C, Heller D, Bornstein J, Roberts J, Preti M . Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review. J Low Genit Tract Dis. 2021; 26(1):32-37. DOI: 10.1097/LGT.0000000000000631. View

13.

Schuurman M, van den Einden L, Massuger L, Kiemeney L, van der Aa M, de Hullu J . Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer. 2013; 49(18):3872-80. DOI: 10.1016/j.ejca.2013.08.003. View

14.

Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32):4294-301. PMC: 3221528. DOI: 10.1200/JCO.2011.36.4596. View

15.

Vieira-Baptista P, Perez-Lopez F, Lopez-Baena M, Stockdale C, Preti M, Bornstein J . Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review. J Low Genit Tract Dis. 2022; 26(3):250-257. DOI: 10.1097/LGT.0000000000000673. View

16.

de Martel C, Plummer M, Vignat J, Franceschi S . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664-670. PMC: 5520228. DOI: 10.1002/ijc.30716. View

17.

Rogers L . Management of Advanced Squamous Cell Carcinoma of the Vulva. Cancers (Basel). 2022; 14(1). PMC: 8750777. DOI: 10.3390/cancers14010167. View

18.

Kang Y, Smith M, Barlow E, Coffey K, Hacker N, Canfell K . Vulvar cancer in high-income countries: Increasing burden of disease. Int J Cancer. 2017; 141(11):2174-2186. DOI: 10.1002/ijc.30900. View

19.

Tailor C, Eley K, Hussain F, Milford C, McMillan R, Hopper C . What the general dental practitioner needs to know about HPV-related oropharyngeal malignancy. Br Dent J. 2020; 229(6):355-360. DOI: 10.1038/s41415-020-2113-6. View

20.

Shinomiya H, Nibu K . Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma. Int J Clin Oncol. 2023; 28(8):975-981. PMC: 10390603. DOI: 10.1007/s10147-023-02336-8. View